ADITXT, INC.

ADITXT

Pharmaceutical preparations and therapeutic agents for modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells to tolerize for specific antigens; pharmaceutical preparations and therapeutic agents for inducing immune tolerance;APOPTOTIC DNA IMMUNOTHERAPY TXT;Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health;Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells to tolerize for specific antigens; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research;

ADITXT IMMUNE HEALTH

The mark consists of an array of seven shaded-in circles arranged in a general square outline with three shaded-in tear drop elements with a shaded-in circle at each end appearing within the square and wherein the tear drop elements are connected together to form linked structures, to the right is the word, ADITXT, appearing above the smaller wording, IMMUNE HEALTH.;Pharmaceutical preparations and therapeutic agents for reprogramming the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance;ADITX THERAPEUTICS IMMUNE HEALTH;Health care services, namely, medical analysis services for diagnostic, treatment and information purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic, treatment and information purposes; advisory services relating to health; providing information in the field of health;IMMUNE HEALTH;Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research; medical laboratory services;